SEC Form 4 · accession 0000905148-16-001678
CytomX Therapeutics, Inc. · CTMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John A Scarlett
Director
Period of report
Jun 10, 2016
Accepted (ET)
Jun 14, 2016 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501989
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $10.17 | Jun 10, 2016 | A | 28,000 | A | — | Jun 9, 2026 | Common Stock | 28,000 | 28,000 | D |
Explanation of responses
- F1This option provides for early exercise and is immediately exercisable. This option vests in 36 substantially equal monthly installments starting on the last day of June 2016 subject to the Reporting Person's continued service to the Issuer through each such date.
Remarks
Exhibit 24.1 - Power of Attorney (incorporated by reference to the Power of Attorney filed as Exhibit 24.1 to the Form 3 filed by the reporting person on June 13, 2016)